In Medical First, a Baby With H.I.V. Is Deemed Cured

http://nyti.ms/ZqBxSo

Some of the HIV fighting big board stocks went crazy on this news.
Here's one that has yet to be discovered.


$ IMMB excellent analysis! PASADENA, CA, - A research report has been issued by Market Advisors, Inc. "Fundamental Analysis for Today's Investments" on Immunotech Laboratories, Inc (PINKSHEETS: IMMB ).
According to the report, Immunotech Laboratories Inc. is committed to beginning clinical trials for its patented IPF Technology to treat HIV/AIDS, Cancer and Hepatitis C. Treatments for HIV/AIDS and cancer and other diseases are always welcome news and this Company appears to have some answers for these health problems which we are all being confronted with, not just here is the U.S., but globally. Immunotech Laboratories Inc. has started restructuring and has added new board members with a goal of up-listing to NASDAQ.